0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Comment & Response |

Temporal Artery Biopsy in Giant Cell Arteritis

Andrzej Grzybowski, MD, PhD1,2; Rebecca C. Stacy, MD, PhD3,4,5
[+] Author Affiliations
1Department of Ophthalmology, Jozef Strus Poznań City Hospital, Poznań, Poland
2Department of Ophthalmology, University of Warmia and Mazury, Olsztyn, Poland
3Department of Ophthalmology, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston
4Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston
5Novartis Institutes for BioMedical Research, Cambridge, Massachusetts
JAMA Ophthalmol. 2015;133(10):1220. doi:10.1001/jamaophthalmol.2015.2552.
Text Size: A A A
Published online

Extract

To the Editor We read with interest the study by De Lott et al,1 but we believe that further discussion is justified. It should be emphasized that the diagnosis of giant cell arteritis (GCA) is based on the combination of clinical picture, laboratory test results (C-reactive protein level [CRP], erythrocyte sedimentation rate [ESR], and platelet count), and histopathological findings.2 Because treatment with corticosteroids must be started as soon as the diagnosis is suspected, temporal artery biopsy (TAB) is usually performed at or after the induction of therapy. In many cases, a positive biopsy result is helpful not just to confirm the diagnosis made on the basis of clinical picture and laboratory tests but also to justify long-term steroid use in patients with a high chance of immunosuppressive-related morbidity. Limiting the evaluation of patients with GCA to clinical and laboratory parameters, even those applied to a statistical model, may result in false-negative results and/or undertreatment of a potentially blinding disease.

Topics

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

Correspondence

October 1, 2015
Lindsey B. De Lott, MD, MS; James F. Burke, MD, MS; Jonathan D. Trobe, MD
1Department of Neurology, University of Michigan, Ann Arbor2Department of Ophthalmology and Visual Sciences, University of Michigan Kellogg Eye Center, Ann Arbor
1Department of Neurology, University of Michigan, Ann Arbor
JAMA Ophthalmol. 2015;133(10):1220-1221. doi:10.1001/jamaophthalmol.2015.2554.
CME
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

615 Views
0 Citations
×

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

See Also...
Jobs
brightcove.createExperiences();